Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women

Applied Physiology, Nutrition and Metabolism

Volumn 37, Issue 5, 2012, Pages 907-911

  Miyaki, Asako ^a   Maeda, Seiji ^a   Choi, Youngju ^a   Akazawa, Nobuhiko ^a   Tanabe, Yoko ^a   Ajisaka, Ryuichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Aging; Exercise; Inflammation

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PENTRAXIN 3; SERUM AMYLOID P;

AGED; AGING; ARTERIAL STIFFNESS; ARTICLE; BICYCLE; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; CLINICAL TRIAL; COMMON CAROTID ARTERY; COMPLIANCE (PHYSICAL); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; EXERCISE; FEMALE; HUMAN; IMMUNOLOGY; JAPAN; MANOMETRY; METABOLISM; MIDDLE AGED; OXYGEN CONSUMPTION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK; WALKING;

AGED; AGING; BICYCLING; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CHOLESTEROL, HDL; COMPLIANCE; EXERCISE; FEMALE; HUMANS; JAPAN; MANOMETRY; MIDDLE AGED; OXYGEN CONSUMPTION; POSTMENOPAUSE; RISK; SERUM AMYLOID P-COMPONENT; VASCULAR STIFFNESS; WALKING;

EID: 84865263320     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/H2012-069     Document Type: Article

References (25)

1. Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W., and Fu, P.C. 1974. Enzymatic determination of total serum cholesterol. Clin. Chem. 20(4): 470-475. PMID:4818200.
2. Chan, Y.C., Suzuki, M., and Yamamoto, S. 1999. A comparison of anthropometry, biochemical variables and plasma amino acids among centenarians, elderly and young subjects. J. Am. Coll. Nutr. 18(4): 358-365. PMID:12038480.
3. Dias, A.A., Goodman, A.R., Dos Santos, J.L., Gomes, R.N., Altmeyer, A., Bozza, P.T., et al. 2001. TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J. Leukoc. Biol. 69(6): 928-936. PMID:11404378.
4. Finley, P.R., Schifman, R.B., Williams, R.J., and Lichti, D.A. 1978. Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymatic measurement. Clin. Chem. 24(6): 931-933. PMID:207463.
5. Fukuda, T., Kurano, M., Iida, H., Takano, H., Tanaka, T., Yamamoto, Y., et al. 2011. Cardiac rehabilitation decreases plasma pentraxin 3 in patients with cardiovascular diseases. Eur. J. Cardiovasc. Prev. Rehabil., In press. PMID:21914683.
6. Kohlmeier, M. 1986. Direct enzymic measurement of glycerides in serum and in lipoprotein fractions. Clin. Chem. 32(1): 63-66. PMID:3510098.
7. Kritchevsky, S.B., Cesari, M., and Pahor, M. 2005. Inflammatory markers and cardiovascular health in older adults. Cardiovasc. Res. 66(2): 265-275. doi:10.1016/j.cardiores.2004.12.026. PMID: 15820195.
8. Mathur, N., and Pedersen, B.K. 2008. Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm. 2008: 109502. doi:10.1155/2008/109502. PMID:19148295.
9. Miyaki, A., Maeda, S., Yoshizawa, M., Misono, M., Saito, Y., Sasai, H., et al. 2009. Effect of habitual aerobic exercise on body weight and arterial function in overweight and obese men. Am. J. Cardiol. 104(6): 823-828. doi:10.1016/j.amjcard.2009.04.057. PMID: 19733718.
10. Miyaki, A., Maeda, S., Otsuki, T., and Ajisaka, R. 2011. Plasma pentraxin 3 concentration increases in endurance-trained men. Med. Sci. Sports Exerc. 43(1): 12-17. doi:10.1249/MSS. 0b013e3181e84bce. PMID:20508541.
11. Nakajima, T., Kurano, M., Hasegawa, T., Takano, H., Iida, H., Yasuda, T., et al. 2010. Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise. Eur. J. Appl. Physiol. 110(5): 905-913. doi:10.1007/s00421-010-1572-x. PMID:20640440.
12. Norata, G.D., Marchesi, P., Pirillo, A., Uboldi, P., Chiesa, G., Maina, V., et al. 2008. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28(5): 925-931. doi:10.1161/ATVBAHA.107.160606. PMID:18218986.
13. Norata, G.D., Marchesi, P., Pulakazhi Venu, P.K., Pasqualini, F., Anselmo, A., Moalli, F., et al. 2009. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation, 120(8): 699-708. doi:10.1161/CIRCULATIONAHA.108.806547. PMID:19667236.
14. Norata, G.D., Garlanda, C., and Catapano, A.L. 2010. The long pentraxin PTX3: A modulator of the immunoinflammatory response in atherosclerosis and cardiovascular disease. Trends Cardiovasc. Med. 20(2): 35-40. doi:10.1016/j.tcm.2010.03.005. PMID:20656213.
15. Petersen, A.M., and Pedersen, B.K. 2005. The anti-inflammatory effect of exercise. J. Appl. Physiol. 98(4): 1154-1162. doi:10.1152/japplphysiol.00164.2004. PMID:15772055.
16. Reckelhoff, J.F. 2006. Cardiovascular disease, estrogen deficiency, and inflammatory cytokines. Hypertension, 48(3): 372-373. doi:10.1161/01.HYP.0000235866.97871.9d. PMID:16864743.
17. Rolph, M.S., Zimmer, S., Bottazzi, B., Garlanda, C., Mantovani, A., and Hansson, G.K. 2002. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 22(5): e10-e14. doi:10.1161/01.ATV.0000015595.95497.2F. PMID:12006411.
18. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362(6423): 801-809. doi:10.1038/362801a0. PMID:8479518.
19. Roubenoff, R. 2007. Physical activity, inflammation, and muscle loss. Nutr. Rev. 65(12): S208-S212. doi:10.1301/nr.2007.dec.S208-S212. PMID:18240550.
20. Safar, M.E., and London, G.M.; The Clinical Committee of Arterial Structure and Function. Working Group on Vascular Structure and Function of the European Society of Hypertension. 2000. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. J. Hypertens. 18(11): 1527-1535. doi:10.1097/00004872-200018110-00001. PMID:11081763.
21. Salio, M., Chimenti, S., De Angelis, N., Molla, F., Maina, V., Nebuloni, M., et al. 2008. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation, 117(8): 1055-1064. doi:10.1161/CIRCULATIONAHA.107.749234. PMID:18268142.
22. Savchenko, A., Imamura, M., Ohashi, R., Jiang, S., Kawasaki, T., Hasegawa, G., et al. 2008. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J. Pathol. 215(1): 48-55. doi:10.1002/path.2314. PMID:18220316.
23. Slein, M.W. 1963. D-Glucose: determination with hexokinase and glucose-6-phosphate dehydrogenase. In Methods of Enzymatic Analysis. Edited by H.U. Bergmeyer. Academic Press, New York, N.Y., USA. p. 117.
24. Wilund, K.R. 2007. Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease? Clin. Sci. 112(11): 543-555. doi:10.1042/CS20060368. PMID:17459004.
25. Yamashita, Y., Nakamura, M., Koizumi, H., Oku, H., Sandoval, J.C., Tsubakio-Yamamoto, K., et al. 2008. Evaluation of a homogeneous assay for measuring LDL-cholesterol in hyperlipidemic serum specimens. J. Atheroscler. Thromb. 15(2): 82-86. doi:10.5551/jat.E527. PMID:18385537.